Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.

What symbol and exchange does Krystal Biotech shares trade?

Krystal Biotech trades on the NASDAQ stock market under the symbol KRYS.

What is Krystal Biotech stock price doing today?

As of November 3, 2026, KRYS stock price climbed to $305.03 with 542,869 million shares trading.

What is Krystal Biotech's Beta?

KRYS has a beta of 0.78, meaning it tends to be less sensitive to market movements. KRYS has a correlation of 0.08 to the broad based SPY ETF.

How much is Krystal Biotech worth?

KRYS has a market cap of $8.92 billion. This is considered a Mid Cap stock.

How much money does Krystal Biotech make?

Last quarter Krystal Biotech reported $127 million in Revenue and $2.05 earnings per share. This beat revenue expectation by $1 million and exceeded earnings estimates by $.15.

What is the highest and lowest price Krystal Biotech traded in the last 3 year period?

In the last 3 years, KRYS traded as high as $382.54 and as low as $93.95.

What are the top ETFs holding Krystal Biotech?

The top ETF exchange traded funds that KRYS belongs to (by Net Assets): IJH, VTI, VB, IWM, XBI.

Is Krystal Biotech (KRYS) a good investment?

KRYS has outperformed the market in the last year with a return of +54.2%, while the SPY ETF gained +11.5%. However, in the most recent history, KRYS shares have underperformed the stock market with its stock returning -2.4% in the last 3 month period and -6.3% for the last 2 week period, while SPY has returned -0.2% and -1.9%, respectively.

What are the support and resistance levels for Krystal Biotech (KRYS)?

KRYS support price is $289.07 and resistance is $302.73 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that KRYS shares will trade within this expected range on the day.